| 标题 |
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a BTLA Agonist Antibody (Venanprubart) in Healthy Participants, Patients with Systemic Lupus Erythematosus, and Patients with Psoriasis: Results From Three Phase 1 Studies |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Pharmacology in Drug Development 作者:Andrew C. Vendel; Olivier Benichou; Ching‐Yun Chang; Gourab Datta; Andrea Ferrante; et al 出版日期:2026 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)